161 related articles for article (PubMed ID: 30370754)
1. High-energy focused extracorporeal shockwave therapy relieved pain in Dupuytren's disease: a series of seven hands.
Abdulsalam AJ; Shehab D; Elhady AA; Abraham M
Eur J Phys Rehabil Med; 2019 Dec; 55(6):862-864. PubMed ID: 30370754
[TBL] [Abstract][Full Text] [Related]
2. Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (DupuyShock).
Knobloch K; Hellweg M; Sorg H; Nedelka T
Lasers Med Sci; 2022 Feb; 37(1):323-333. PubMed ID: 33483776
[TBL] [Abstract][Full Text] [Related]
3. High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose's disease).
Knobloch K; Vogt PM
BMC Res Notes; 2012 Oct; 5():542. PubMed ID: 23031080
[TBL] [Abstract][Full Text] [Related]
4. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis.
Knobloch K; Kuehn M; Vogt PM
Med Hypotheses; 2011 May; 76(5):635-7. PubMed ID: 21277691
[TBL] [Abstract][Full Text] [Related]
5. Radial extracorporeal shock wave therapy: a novel approach for the treatment of Dupuytren's contractures: A case report.
Brunelli S; Bonanni C; Traballesi M; Foti C
Medicine (Baltimore); 2020 Jun; 99(24):e20587. PubMed ID: 32541491
[TBL] [Abstract][Full Text] [Related]
6. [An attempt to objectify the assessment of extension or recurrence of Dupuytren's disease on the basis of ultrasound].
Bednarek M; Trybus M; Wiśniowski Z; Budzyński P; Gniadek M
Przegl Lek; 2012; 69(12):1266-70. PubMed ID: 23750436
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren's disease: limited fasciectomy, night splinting, and hand exercises-long-term results.
Kitridis D; Karamitsou P; Giannaros I; Papadakis N; Sinopidis C; Givissis P
Eur J Orthop Surg Traumatol; 2019 Feb; 29(2):349-355. PubMed ID: 30413875
[TBL] [Abstract][Full Text] [Related]
8. Dupuytren's disease: history, diagnosis, and treatment.
Shaw RB; Chong AKS; Zhang A; Hentz VR; Chang J
Plast Reconstr Surg; 2007 Sep; 120(3):44e-54e. PubMed ID: 17700106
[TBL] [Abstract][Full Text] [Related]
9. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.
Ball C; Pratt AL; Nanchahal J
BMC Musculoskelet Disord; 2013 Apr; 14():131. PubMed ID: 23575442
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal Shock Wave Therapy in Dupuytren's Disease.
Aykut S; Aydın C; Öztürk K; Arslanoğlu F; Kılınç CY
Sisli Etfal Hastan Tip Bul; 2018; 52(2):124-128. PubMed ID: 32595385
[TBL] [Abstract][Full Text] [Related]
11. Dupuytren's palmar contracture in women.
Stahl S; Calif E
Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
[TBL] [Abstract][Full Text] [Related]
12. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis.
Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T
Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030
[TBL] [Abstract][Full Text] [Related]
13. Short-term effect of shockwave therapy, temperature controlled high energy adjustable multi-mode emission laser or stretching in Dupuytren’s disease: a prospective randomized clinical trial.
Notarnicola A; Maccagnano G; Rifino F; Pesce V; Gallone MF; Covelli I; Moretti B
J Biol Regul Homeost Agents; 2017; 31(3):775-784. PubMed ID: 28958137
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease.
Scheibler AG; Marks M; Hensler S; Herren DB; Calcagni M
Arch Orthop Trauma Surg; 2019 Apr; 139(4):583-588. PubMed ID: 30673868
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review of the management of Dupuytren's nodules.
Reilly RM; Stern PJ; Goldfarb CA
J Hand Surg Am; 2005 Sep; 30(5):1014-8. PubMed ID: 16182060
[TBL] [Abstract][Full Text] [Related]
16. Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren's disease.
Rodrigues J; Zhang W; Scammell B; Russell P; Chakrabarti I; Fullilove S; Davidson D; Davis T
J Hand Surg Eur Vol; 2016 Jul; 41(6):589-99. PubMed ID: 26307142
[TBL] [Abstract][Full Text] [Related]
17. Dupuytren's contracture in a patient with type 2 diabetes mellitus--a case report.
Puepet FH; Uloko AE; Yiltok SJ; Mijinyawa B
Niger J Med; 2007; 16(4):384-6. PubMed ID: 18080603
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
19. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
[TBL] [Abstract][Full Text] [Related]
20. Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial.
Aglen T; Matre KH; Lind C; Selles RW; Aßmus J; Taule T
BMC Musculoskelet Disord; 2019 Aug; 20(1):387. PubMed ID: 31455312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
